HUTCHMED (China) Limited (H7T2)
FSX
Real-time Data
06:00 AM
Day's Range
2.0852 wk Range
1.65Overview - H7T2 - HUTCHMED (China) Limited
Key Statistics
Valuation
Enterprise Value
380.48M
P/E (Trailing)
‪98.50‬
Price / Sales (TTM)
‪3.11‬
Price / Book
‪1.57‬
EV / EBITDA
‪-21.65‬
Profitability
Gross Margin
‪23.08%‬
Profit Margin
‪3.25%‬
Operating Margin
‪0.31%‬
Return on Assets
‪-1.23%‬
Return on Equity
‪1.46%‬
Ownership
Shares Outstanding
859.74M
Float
522.93M
Held by Insiders
‪38.79%‬
Held by Institutions
‪19.43%‬
Price stats
Beta
‪0.43‬
50-Day Avg
‪1.86‬
200-Day Avg
‪2.15‬
Dividends
Payout Ratio
‪0.00%‬
Peers - H7T2 - HUTCHMED (China) Limited
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
Profile Summary - H7T2 - HUTCHMED (China) Limited
About
HUTCHMED (China) Limited is an innovative, commercial-stage biopharmaceutical company headquartered in Hong Kong, focused on the discovery, global development, and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases. Established over two decades ago as one of China's first…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
